Scarica l'app Stockscreener
69.01
0.41%
0.2885
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$68.72
Aprire:
$68.6
Volume 24 ore:
44,177
Relative Volume:
0.05
Capitalizzazione di mercato:
$10.92B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
45.40
EPS:
1.52
Flusso di cassa netto:
$245.03M
1 W Prestazione:
-4.88%
1M Prestazione:
-1.93%
6M Prestazione:
-16.55%
1 anno Prestazione:
+8.63%
Intervallo 1D:
$68.42
$69.16
Intervallo di 1 settimana:
$65.61
$72.47
Portata 52W:
$61.16
$85.57
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| TECH | 69.04 | 10.92B | 1.17B | 150.71M | 245.03M | 1.52 |
| VRTX | 447.51 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.90 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.12 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.75 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.52 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Natixis Advisors LLC - MarketBeat
Thrivent Financial for Lutherans Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? - MSN
Bio-Techne To Present At Stephens NASH 2024 Conference; Webcast At 12:00 PM ET - Nasdaq
Bio-Techne partners with Leader Life Sciences in GCC - Investing.com
Segall Bryant & Hamill LLC Has $38.20 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES - Yahoo Finance
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH - Quantisnow
Broadcrest Asset Management LLC Has $15.99 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Royce & Associates LP Acquires 17,296 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO - Quantisnow
Geneva Capital Management LLC Has $88.27 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne To Present At UBS Global Healthcare Conference; Webcast At 12:30 PM ET - Nasdaq
Bio-Techne (NASDAQ:TECH) Raised to Buy at StockNews.com - MarketBeat
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES - Marketscreener.com
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow
Bio-Techne Co. (NASDAQ:TECH) is Montanaro Asset Management Ltd's 3rd Largest Position - MarketBeat
Ownership Capital B.V. Sells 208,493 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
When the Price of (TECH) Talks, People Listen - Stock Traders Daily
Bio-Techne Corporation: An Insight Into Its Market Position & Product Expansion in Diagnostics and Spatial Biology!Major Drivers - Smartkarma
Asset Management One Co. Ltd. Has $9.69 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy - Quantisnow
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Van ECK Associates Corp - MarketBeat
There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings - Yahoo Finance
Ex-Dividend Reminder: Bio-Techne, Pfizer and Tompkins Financial - Nasdaq
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING - WV News
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - Yahoo Finance
Bio-Techne (FRA:TE1) Change In Receivables : €-33 Mil (TTM As of Sep. 2024) - GuruFocus.com
Bio-Techne Corporation (TECH) Announces Executive Compensation U - GuruFocus.com
Bio-Techne awards CFO restricted stock units for retention - Investing.com
TECH (Bio-Techne) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH - Quantisnow
Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket - MSN
Bio-Techne Corp (TECH)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus.com
New York State Common Retirement Fund Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne (NASDAQ:TECH) Upgraded to Buy at StockNews.com - MarketBeat
9 Best Biotech Stocks Of November 2024 - Forbes
Bio-Techne Corporation (NASDAQ:TECH) Q1 2025 Earnings Call Transcript - Insider Monkey
TECH (Bio-Techne) Total Inventories : $185 Mil (As of Sep. 2024) - GuruFocus.com
Bio-Techne Tops Profit Forecasts Thanks To Booming Diagnostics - Finimize
Bio-Techne shares target raised, outperform on strong Q1 results By Investing.com - Investing.com Australia
Earnings call: Bio-Techne reports steady growth in Q1 FY2025 - Investing.com
Earnings call: Bio-Techne reports steady growth in Q1 FY2025 By Investing.com - Investing.com UK
Bio-Techne shares target raised, outperform on strong Q1 results - Investing.com India
Robert W. Baird Forecasts Strong Price Appreciation for Bio-Techne (NASDAQ:TECH) Stock - MarketBeat
Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigat - GuruFocus.com
Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... - Yahoo Finance
Bio-Techne holds at $80 target with Overweight rating - Investing.com India
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hippel James | CFO |
Nov 01 '24 |
Option Exercise |
0.00 |
13,159 |
0 |
113,085 |
| HIGGINS JOHN L | Director |
Sep 12 '24 |
Option Exercise |
22.95 |
6,000 |
137,700 |
48,608 |
| Kelderman Kim | Chief Executive Officer |
Aug 29 '24 |
Option Exercise |
66.97 |
1,492 |
99,919 |
41,434 |
| Bohnen Shane | SVP - General Counsel |
Aug 15 '24 |
Option Exercise |
0.00 |
49 |
0 |
1,696 |
| BAUMGARTNER ROBERT V | Director |
Aug 08 '24 |
Option Exercise |
22.95 |
16,000 |
367,200 |
59,401 |
| BAUMGARTNER ROBERT V | Director |
Aug 08 '24 |
Sale |
72.10 |
16,000 |
1,153,664 |
43,401 |
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):